Atlas Trials

Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children

Clinical trial NCT01431170 · COMPLETED

Trial details

NCT number
NCT01431170
Sponsor
Rutgers, The State University of New Jersey
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Congenital Nasolacrimal Duct Obstruction
Start date
2011-09-01
Primary completion
2014-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.